Estia Health Ltd announces expansion plans: Is the stock a buy?

Estia Health Ltd (ASX:EHE) listed on the ASX late last year, following the successful floats of rivals Japara Healthcare Ltd (ASX:JHC) and Regis Healthcare Ltd (ASX:REG).

a woman

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

Shares of listed residential aged care operator Estia Health Ltd (ASX: EHE) rose higher on Thursday after the company announced its plans to develop in excess of 500 additional aged care beds by the end of the 2019 fiscal year.

Estia said that it has entered into an agreement with Living Choice Australia Ltd, which is one of Australia's largest privately owned retirement village companies, to build two new facilities on the Sunshine Coast in Queensland.

This initiative will help it work towards its strategic plan to achieve 10,000 aged care beds by 2020, as well as its target of 500 to 1,000 places through greenfield developments, also by 2020.

The location of the facilities is also important. Australia's population is aging and growing at a rapid clip – a trend that is expected to continue over the coming decades. While the services provided by aged care facilities will thus become increasingly important, it is those who provide the best services in the most ideal locations that will likely benefit the most.

Estia Health's Chief Executive Officer, Paul Gregersen, said: "Queensland is an increasingly important market for Estia's growth plans and securing two additional residential aged care facilities on the Sunshine Coast, with its ageing population and strong socio-economic demographic, represents a very attractive proposition for the group."

Estia listed on the Australian Securities Exchange late last year following the successful floats of rivals Japara Healthcare Ltd (ASX: JHC) and Regis Healthcare Ltd (ASX: REG). Although it got off to a very shaky start, the stock has risen strongly in the months since, but still appears to be a promising investment case for 'Foolish', long-term investors.

Motley Fool contributor Ryan Newman has no position in any stocks mentioned. You can follow Ryan on Twitter @ASXvalueinvest. The Motley Fool Australia has no position in any of the stocks mentioned. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Bruce Jackson.

More on ⏸️ Investing

Close up of baby looking puzzled
Retail Shares

What has happened to the Baby Bunting (ASX:BBN) share price this year?

It's been a volatile year so far for the Aussie nursery retailer. We take a closer look

Read more »

woman holds sign saying 'we need change' at climate change protest
ETFs

3 ASX ETFs that invest in companies fighting climate change

If you want to shift some of your investments into more ethical companies, exchange-traded funds can offer a good option

Read more »

a jewellery store attendant stands at a cabinet displaying opulent necklaces and earrings featuring diamonds and precious stones.
⏸️ Investing

The Michael Hill (ASX: MHJ) share price poised for growth

Investors will be keeping an eye on the Michael Hill International Limited (ASX: MHJ) share price today. The keen interest…

Read more »

ASX shares buy unstoppable asx share price represented by man in superman cape pointing skyward
⏸️ Investing

The Atomos (ASX:AMS) share price is up 15% in a week

The Atomos (ASX: AMS) share price has surged 15% this week. Let's look at what's ahead as the company build…

Read more »

Two people in suits arm wrestle on a black and white chess board.
Retail Shares

How does the Temple & Webster (ASX:TPW) share price stack up against Nick Scali (ASX:NCK)?

How does the Temple & Webster (ASX: TPW) share price stack up against rival furniture retailer Nick Scali Limited (ASX:…

Read more »

A medical researcher works on a bichip, indicating share price movement in ASX tech companies
Healthcare Shares

The Aroa (ASX:ARX) share price has surged 60% since its IPO

The Aroa (ASX:ARX) share price has surged 60% since the Polynovo (ASX: PNV) competitor listed on the ASX in July.…

Read more »

asx investor daydreaming about US shares
⏸️ How to Invest

How to buy US shares from Australia right now

If you have been wondering how to buy US shares from Australia to gain exposure from the highly topical market,…

Read more »

⏸️ Investing

Why Fox (NASDAQ:FOX) might hurt News Corp (ASX:NWS) shareholders

News Corporation (ASX: NWS) might be facing some existential threats from its American cousins over the riots on 6 January

Read more »